Here s Why Raptor Pharmaceuticals Corp #industry #pharmacy

Posted On May 16 2017 by

#raptor pharma # Here s Why Raptor Pharmaceuticals Corp. Plunged Today Sep 14, 2015 at 11:39AM What. Raptor Pharmaceuticals (NASDAQ:RPTP ). a small-cap biopharma company specializing in the development of treatments for rare diseases, saw its stock plunge by nearly 40% today on heavy volume. This massive downward move was precipitated by the announcement that the company’s experimental drug for nonalcoholic steatohepatitis (NASH) in children, RP103, failed to meet its primary endpoint in a second mid-stage trial. Because RP103 reportedly failed to make any meaningful impact on liver fibrosis, Raptor expects to discontinue the drug’s clinical program for NASH following …


Sick of pharmaceutical ads? Here – s why they won – t go away #dalton #pharma #services

Posted On Apr 30 2017 by

#pharmaceutical advertising # It seems like every other billboard and commercial in the U.S. is for a prescription drug. And yet consumers can t buy them without a doctor s approval. So why target consumers with these ads? Do we really have that much influence over physicians? Here s how the U.S. became one of the only countries in the world where pharmaceutical companies peddle drugs to ordinary people. Food and Drug Administration Loopholes The United States and New Zealand are the only countries in the world that allow direct-to-consumer advertising of pharmaceuticals. Most countries banned the practice in the …


Raptor Pharma to Stop Development of Liver Drug: Here – s Why: Healthy Living #d #pharma

Posted On Apr 21 2017 by

#raptor pharma # Raptor Pharma to Stop Development of Liver Drug: Here s Why Raptor Pharma announced that it will no longer pursue the development of its experimental drug RP103 as treatment for the liver disease Nonalcoholic steatohepatitis in children. (Photo. Bill Brooks | Flickr) Raptor Pharmaceutical Corporation is pulling the plug on an experimental drug as treatment for a liver disease. In a statement released on Monday, Sept.14, the biopharmaceutical company said that the drug called RP103 (cysteamine bitartrate) did not meet the main goals in the Phase 2b CyNCh study. The study, which involved 169 participants between 8 …


Here are 10 of the fastest growing health IT companies, according to Inc #pharmaceutical #industry #history

Posted On Apr 21 2017 by

#health it companies # Here are 10 of the fastest growing health IT companies, according to Inc. The interest in using health IT tools as a way to improve healthcare delivery and efficiency has produced many rapidly growing healthcare companies, many of which can trace their origins within one or two years of Obamacare s passage. These companies have reached a stage of their development to accelerate growth and that has coincided with a readiness by healthcare providers and payers to adopt or ramp up their technology. With a nod to the top healthcare company on Inc s 5,000 Fastest …


Here s Why Raptor Pharmaceuticals Corp #pharmaceutical #recruiters

Posted On Apr 12 2017 by

#raptor pharma # Here s Why Raptor Pharmaceuticals Corp. Plunged Today Sep 14, 2015 at 11:39AM What. Raptor Pharmaceuticals (NASDAQ:RPTP ). a small-cap biopharma company specializing in the development of treatments for rare diseases, saw its stock plunge by nearly 40% today on heavy volume. This massive downward move was precipitated by the announcement that the company’s experimental drug for nonalcoholic steatohepatitis (NASH) in children, RP103, failed to meet its primary endpoint in a second mid-stage trial. Because RP103 reportedly failed to make any meaningful impact on liver fibrosis, Raptor expects to discontinue the drug’s clinical program for NASH following …


Sick of pharmaceutical ads? Here – s why they won – t go away #pharmaceutical #companies #in #charlotte #nc

Posted On Apr 12 2017 by

#pharmaceutical advertising # It seems like every other billboard and commercial in the U.S. is for a prescription drug. And yet consumers can t buy them without a doctor s approval. So why target consumers with these ads? Do we really have that much influence over physicians? Here s how the U.S. became one of the only countries in the world where pharmaceutical companies peddle drugs to ordinary people. Food and Drug Administration Loopholes The United States and New Zealand are the only countries in the world that allow direct-to-consumer advertising of pharmaceuticals. Most countries banned the practice in the …


Here are 10 of the fastest growing health IT companies, according to Inc #pharma #manufacturing #process

Posted On Apr 11 2017 by

#health it companies # Here are 10 of the fastest growing health IT companies, according to Inc. The interest in using health IT tools as a way to improve healthcare delivery and efficiency has produced many rapidly growing healthcare companies, many of which can trace their origins within one or two years of Obamacare s passage. These companies have reached a stage of their development to accelerate growth and that has coincided with a readiness by healthcare providers and payers to adopt or ramp up their technology. With a nod to the top healthcare company on Inc s 5,000 Fastest …


Pharmacom Labs Worldwide Official Distributor since 2008 – Buy Here #phrma

Posted On Apr 9 2017 by

#pharma.com # PULSE Trenbolone for the Very First Steroid Cycle Q: Your articles have two pieces of advice that are totally contrary to recommendations I read on boards everywhere. One, even for a guy s very first cycle you seem to like choosing trenbolone. Everywhere else, the vets shoot that down when anyone suggests that s what they want to do for a first cycle. You also write cycles up around a gram per week for first cycles. Same thing. Are those old recommendations which you ve since changed, or is there a reason behind them? A: I still often …


Here s Why Raptor Pharmaceuticals Corp #intas #pharma

Posted On Mar 20 2017 by

#raptor pharma # Here s Why Raptor Pharmaceuticals Corp. Plunged Today Sep 14, 2015 at 11:39AM What. Raptor Pharmaceuticals (NASDAQ:RPTP ). a small-cap biopharma company specializing in the development of treatments for rare diseases, saw its stock plunge by nearly 40% today on heavy volume. This massive downward move was precipitated by the announcement that the company’s experimental drug for nonalcoholic steatohepatitis (NASH) in children, RP103, failed to meet its primary endpoint in a second mid-stage trial. Because RP103 reportedly failed to make any meaningful impact on liver fibrosis, Raptor expects to discontinue the drug’s clinical program for NASH following …


Pharmacom Labs Worldwide Official Distributor since 2008 – Buy Here #west #pharma

Posted On Mar 18 2017 by

#pharma.com # PULSE Trenbolone for the Very First Steroid Cycle Q: Your articles have two pieces of advice that are totally contrary to recommendations I read on boards everywhere. One, even for a guy s very first cycle you seem to like choosing trenbolone. Everywhere else, the vets shoot that down when anyone suggests that s what they want to do for a first cycle. You also write cycles up around a gram per week for first cycles. Same thing. Are those old recommendations which you ve since changed, or is there a reason behind them? A: I still often …